Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial-Reference-Cited by-同舟云学术

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

Published:2012-07 Issue:9838 Volume:380 Page:238-246
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Kirchhof Paulus,Andresen Dietrich,Bosch Ralph,Borggrefe Martin,Meinertz Thomas,Parade Ulli,Ravens Ursula,Samol Alexander,Steinbeck Gerhard,Treszl Andras,Wegscheider Karl,Breithardt Günter

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study;Benjamin;Circulation,1998

2. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study;Wang;JAMA,2003

3. Guidelines for the management of atrial fibrillation;Camm;Eur Heart J,2010

4. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial;Kirchhof;Lancet,2002

5. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial;Fetsch;Eur Heart J,2004

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

2. Therapeutic potential of flecainide for cardiac arrhythmias: a short review of studies and clinical recommendations;Journal of Arrhythmology;2024-08-22

3. Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial;Europace;2024-05-04

4. The Resurgence of Flecainide;Cardiology Research;2024-04

5. Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference;Europace;2024-03-30